P2RY2 and breast carcinoma: A previous study showed altered purinergic receptor-Ca2+ signaling in endothelial growth factor (EGF)-induced epithelial–mesenchymal transition (EMT) and later in hypoxia-induced EMT in breast cancer cells [18,19].